These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28296286)

  • 21. Nanoparticulate immunotherapy for cancer.
    Kapadia CH; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2015 Dec; 219():167-180. PubMed ID: 26432555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.
    Kelley WJ; Safari H; Lopez-Cazares G; Eniola-Adefeso O
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):909-926. PubMed ID: 27194461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide nanostructures in biomedical technology.
    Feyzizarnagh H; Yoon DY; Goltz M; Kim DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):730-43. PubMed ID: 26846352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biogenic nanoparticles as immunomodulator for tumor treatment.
    Cheng K; Kang Q; Zhao X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1646. PubMed ID: 32464709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
    Cheng CT; Castro G; Liu CH; Lau P
    Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted nanoparticles for head and neck cancers: overview and perspectives.
    Zhao Y; Chen H; Chen X; Hollett G; Gu Z; Wu J; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28387452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
    Pan H; Soman NR; Schlesinger PH; Lanza GM; Wickline SA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(3):318-27. PubMed ID: 21225660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breaking Down the Barriers to Precision Cancer Nanomedicine.
    von Roemeling C; Jiang W; Chan CK; Weissman IL; Kim BYS
    Trends Biotechnol; 2017 Feb; 35(2):159-171. PubMed ID: 27492049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Helical coiled-coil peptide materials for biomedical applications.
    Wu Y; Collier JH
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27597649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology in the arena of cancer immunotherapy.
    Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
    Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional platinum-based nanoparticles for biomedical applications.
    Cheng Q; Liu Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric Micelles in Cancer Immunotherapy.
    Wan Z; Zheng R; Moharil P; Liu Y; Chen J; Sun R; Song X; Ao Q
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33668746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.
    Wadajkar AS; Dancy JG; Hersh DS; Anastasiadis P; Tran NL; Woodworth GF; Winkles JA; Kim AJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 27813323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal micro, nano, and size conversion ultrasound agents for imaging and therapy.
    Huynh E; Rajora MA; Zheng G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):796-813. PubMed ID: 27006001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional carbon nanodots for multiscale imaging and therapy.
    Ostadhossein F; Pan D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27791335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.
    Colby AH; Oberlies NH; Pearce CJ; Herrera VL; Colson YL; Grinstaff MW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 28185434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
    Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifying the tumor microenvironment using nanoparticle therapeutics.
    Roy A; Li SD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):891-908. PubMed ID: 27038329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.